Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Swine Influenza Vaccines Market Research Report 2019-2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Swine Influenza Vaccines Industry
  • 1.7 COVID-19 Impact: Swine Influenza Vaccines Market Trends

    • 2 Global Swine Influenza Vaccines Quarterly Market Size Analysis

    • 2.1 Swine Influenza Vaccines Business Impact Assessment - COVID-19
      • 2.1.1 Global Swine Influenza Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Swine Influenza Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Swine Influenza Vaccines Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Swine Influenza Vaccines Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Swine Influenza Vaccines Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Swine Influenza Vaccines Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Swine Influenza Vaccines Market
    • 3.5 Key Manufacturers Swine Influenza Vaccines Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Swine Influenza Vaccines Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Live Vaccines
      • 1.4.2 Killed Vaccines
    • 4.2 By Type, Global Swine Influenza Vaccines Market Size, 2019-2021
      • 4.2.1 By Type, Global Swine Influenza Vaccines Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Swine Influenza Vaccines Price, 2020-2021

    5 Impact of Covid-19 on Swine Influenza Vaccines Segments, By Application

    • 5.1 Overview
      • 5.5.1 Commodity Pig
      • 5.5.2 Breeding Pig
    • 5.2 By Application, Global Swine Influenza Vaccines Market Size, 2019-2021
      • 5.2.1 By Application, Global Swine Influenza Vaccines Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Swine Influenza Vaccines Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Chengdu TECBOND
      • 7.1.1 Chengdu TECBOND Business Overview
      • 7.1.2 Chengdu TECBOND Swine Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.1.3 Chengdu TECBOND Swine Influenza Vaccines Product Introduction
      • 7.1.4 Chengdu TECBOND Response to COVID-19 and Related Developments
    • 7.2 Green Cross Veterinary
      • 7.2.1 Green Cross Veterinary Business Overview
      • 7.2.2 Green Cross Veterinary Swine Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.2.3 Green Cross Veterinary Swine Influenza Vaccines Product Introduction
      • 7.2.4 Green Cross Veterinary Response to COVID-19 and Related Developments
    • 7.3 Hipra
      • 7.3.1 Hipra Business Overview
      • 7.3.2 Hipra Swine Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.3.3 Hipra Swine Influenza Vaccines Product Introduction
      • 7.3.4 Hipra Response to COVID-19 and Related Developments
    • 7.4 MSD Animal Health (Merck)
      • 7.4.1 MSD Animal Health (Merck) Business Overview
      • 7.4.2 MSD Animal Health (Merck) Swine Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Product Introduction
      • 7.4.4 MSD Animal Health (Merck) Response to COVID-19 and Related Developments
    • 7.5 Zoetis
      • 7.5.1 Zoetis Business Overview
      • 7.5.2 Zoetis Swine Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.5.3 Zoetis Swine Influenza Vaccines Product Introduction
      • 7.5.4 Zoetis Response to COVID-19 and Related Developments
    • 7.6 CAHIC
      • 7.6.1 CAHIC Business Overview
      • 7.6.2 CAHIC Swine Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.6.3 CAHIC Swine Influenza Vaccines Product Introduction
      • 7.6.4 CAHIC Response to COVID-19 and Related Developments
    • 7.7 Merial
      • 7.7.1 Merial Business Overview
      • 7.7.2 Merial Swine Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.7.3 Merial Swine Influenza Vaccines Product Introduction
      • 7.7.4 Merial Response to COVID-19 and Related Developments
    • 7.8 Ceva
      • 7.8.1 Ceva Business Overview
      • 7.8.2 Ceva Swine Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.8.3 Ceva Swine Influenza Vaccines Product Introduction
      • 7.8.4 Ceva Response to COVID-19 and Related Developments
    • 7.9 Ringpu Biology
      • 7.9.1 Ringpu Biology Business Overview
      • 7.9.2 Ringpu Biology Swine Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.9.3 Ringpu Biology Swine Influenza Vaccines Product Introduction
      • 7.9.4 Ringpu Biology Response to COVID-19 and Related Developments
    • 7.10 DHN
      • 7.10.1 DHN Business Overview
      • 7.10.2 DHN Swine Influenza Vaccines Quarterly Production and Revenue, 2020
      • 7.10.3 DHN Swine Influenza Vaccines Product Introduction
      • 7.10.4 DHN Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Swine Influenza Vaccines Supply Chain Analysis
      • 8.1.1 Swine Influenza Vaccines Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Swine Influenza Vaccines Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Swine Influenza Vaccines Distribution Channels
      • 8.2.2 Covid-19 Impact on Swine Influenza Vaccines Distribution Channels
      • 8.2.3 Swine Influenza Vaccines Distributors
    • 8.3 Swine Influenza Vaccines Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Swine Influenza Vaccines, including the following market information:
      Global Swine Influenza Vaccines Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Swine Influenza Vaccines Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Swine Influenza Vaccines Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Swine Influenza Vaccines Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Chengdu TECBOND, Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Zoetis, CAHIC, Merial, Ceva, Ringpu Biology, DHN, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Live Vaccines
      Killed Vaccines

      Based on the Application:
      Commodity Pig
      Breeding Pig

      Buy now